ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in Use on Ibuprofen 200mg And 400mg Tablets

Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
6835151IBUPROFEN TAB 200MGASPAR PHARMACEUTICALSPlease refer to link above
6835169IBUPROFEN TAB 200MGASPAR PHARMACEUTICALSPlease refer to link above
1000132IBUPROFEN TAB 200MGASPAR PHARMACEUTICALSPlease refer to link above
1038892IBUPROFEN TAB 200MGASPAR PHARMACEUTICALSPlease refer to link above
1077601IBUPROFEN TAB 200MGASPAR PHARMACEUTICALSPlease refer to link above
1187509IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above
6835177IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above
6835185IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above
1058262IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above
1130509IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above
1130491IBUPROFEN TAB 400MGASPAR PHARMACEUTICALSPlease refer to link above

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.